Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Humana
(NY:
HUM
)
363.86
-2.80 (-0.76%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Humana
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
62
63
Next >
Humana Board Declares Payment of Quarterly Dividend to Stockholders
February 20, 2025
From
Humana Inc.
Via
Business Wire
CenterWell Poised for Further Primary Care Expansion in 2025
February 19, 2025
From
Humana Inc.
Via
Business Wire
Looking Into Humana's Recent Short Interest
↗
February 17, 2025
Via
Benzinga
Humana and Monogram Health Announce Expansion of Comprehensive Kidney Care Program
February 13, 2025
From
Humana Inc.
Via
Business Wire
Deep Dive Into Humana Stock: Analyst Perspectives (7 Ratings)
↗
February 12, 2025
Via
Benzinga
Here's How Much You Would Have Made Owning Humana Stock In The Last 20 Years
↗
February 11, 2025
Via
Benzinga
Humana 2025 Outlook Shows Cautious Optimism Despite Industry Pressures
↗
February 12, 2025
Humana reported a Q4 adjusted EPS loss of $2.16 while revenue grew 13.5% year-over-year to $29.19 billion.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
February 12, 2025
Via
Benzinga
Which S&P500 stocks are moving on Tuesday?
↗
February 11, 2025
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday.
Via
Chartmill
Why Humana (HUM) Shares Are Getting Obliterated Today
February 11, 2025
Shares of health insurance company Humana (NYSE:HUM) fell 8.2% in the afternoon session after the company reported mixed fourth-quarter results: Earnings and adjusted EBITDA missed Wall Street's...
Via
StockStory
US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday?
↗
February 11, 2025
U.S.
Via
Benzinga
Stay informed with the top movers within the S&P500 index on Tuesday.
↗
February 11, 2025
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Via
Chartmill
What's going on in today's pre-market session: S&P500 movers
↗
February 11, 2025
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top S&P500 gainers and losers in today's pre-market session.
Via
Chartmill
Humana Stock Stirs Retail Buzz After Mixed Q4, Steeper Medicare Advantage Decline Forecast
↗
February 11, 2025
CEO Jim Rechtin called 2025 “a critical step in returning to compelling, normalized margins.”
Via
Stocktwits
Insurance Giant Humana's Q4 Earnings: 13% Revenue Growth, 2025 Profit Outlook Falls Below Street View
↗
February 11, 2025
Humana reported a Q4 revenue beat at $29.19 billion but saw an adjusted EPS loss. The insurer forecasts 2025 sales of up to $128 billion and a 10% Medicare Advantage decline.
Via
Benzinga
CVS Health (CVS) Q4 Earnings Report Preview: What To Look For
February 11, 2025
Diversified healthcare company CVS Health (NYSE:CVS) will be announcing earnings results tomorrow morning. Here’s what investors should know.
Via
StockStory
Humana (NYSE:HUM) Beats Q4 Sales Targets, Guides for Strong Full-Year Sales
February 11, 2025
Health insurance company Humana (NYSE:HUM) announced better-than-expected revenue in Q4 CY2024, with sales up 13.5% year on year to $29.21 billion. The company’s full-year revenue guidance of $127...
Via
StockStory
Topics
Artificial Intelligence
Economy
Fraud
Humana Reports Fourth Quarter 2024 Financial Results; Provides Full Year 2025 Financial Guidance
February 11, 2025
From
Humana Inc.
Via
Business Wire
Humana Earnings On Deck: Investors Brace For Slower Growth Clip
↗
February 10, 2025
Humana to release Q4 2024 earnings on Feb. 11 before market hours. Previous quarter saw 15.2% revenue increase, EPS beat but missed guidance.
Via
Benzinga
Gapping S&P500 stocks in Monday's session
↗
February 10, 2025
Let's have a look at the S&P500 gap up and gap down stocks in today's session.
Via
Chartmill
Humana (HUM) Q4 Earnings: What To Expect
February 10, 2025
Health insurance company Humana (NYSE:HUM) will be reporting results tomorrow before market hours. Here’s what to expect.
Via
StockStory
Value-Based Care Simplifies Healthcare for Patients and Clinicians, New Report Finds
February 05, 2025
From
Humana Inc.
Via
Business Wire
Earnings Scheduled For February 11, 2025
↗
February 11, 2025
Via
Benzinga
ASSOCIATION OF PICKLEBALL PLAYERS AND HUMANA ANNOUNCE MULTI-YEAR PARTNERSHIP EXTENSION
February 04, 2025
ASSOCIATION OF PICKLEBALL PLAYERS AND HUMANA ANNOUNCE MULTI-YEAR PARTNERSHIP EXTENSION
Via
News Direct
Cigna Misses EPS: What It Means for the Health Insurance Industry
February 04, 2025
Cigna is one of the most efficiently managed health insurance companies evidenced by its foresight to sell its Medicare Advantage business before the fallout.
Via
MarketBeat
Cigna Group Stock Drops To Near 4-Week Low After Big Profit Miss, Retail Turns Bearish
↗
January 30, 2025
The company revised its full-year 2025 adjusted EPS to $29.50, below the $31.48 estimate, and projected adjusted revenue of at least $252 billion.
Via
Stocktwits
RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders
↗
January 29, 2025
Kennedy seeks to be Secretary of Health and Human Services — a position that would put him in charge of the health of the American people.
Via
Benzinga
Topics
Government
Momentum Grows for These 3 Healthcare Stocks
January 28, 2025
As the market starts to reflect on the potential tail risks in the S&P 500, a rotation has shown itself in three stocks in the healthcare sector.
Via
MarketBeat
Topics
Stocks
Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review
↗
January 17, 2025
Many stocks flashed buy signals as the major indexes rose to or above key levels.
Via
Investor's Business Daily
Topics
Economy
Insurance, Pharmacy Benefit Manager Company Stocks Drop Following UnitedHealth's Q4 Revenue Miss: What's Going On?
↗
January 16, 2025
Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are trading lower Thursday, likely in reaction to UnitedHealth Group's...
Via
Benzinga
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
62
63
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.